242 related articles for article (PubMed ID: 38216941)
1. Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.
Yang M; Yao X; Xia F; Xiang S; Tang W; Zhou B
BMC Complement Med Ther; 2024 Jan; 24(1):36. PubMed ID: 38216941
[TBL] [Abstract][Full Text] [Related]
2. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
[TBL] [Abstract][Full Text] [Related]
3. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ.
Yang M; Chen Z; Xiang S; Xia F; Tang W; Yao X; Zhou B
BMC Complement Med Ther; 2020 Dec; 20(1):377. PubMed ID: 33308192
[TBL] [Abstract][Full Text] [Related]
4. [Effects of sera of rats fed with
Yang M; Chen Z; Xiao C; Tang W; Zhou B
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1277-1287. PubMed ID: 30514673
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].
Yao XR; Xia F; Tang WJ; Zhou BJ
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):56-62. PubMed ID: 28109099
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of Gegen Qinlian Decoction in improving glucose metabolism in vitro and in vivo by alleviating hepatic endoplasmic reticulum stress].
Jiang Y; Yan LK; Wang Y; Ding JF; Xu ZH; Cui C; Tu J
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5565-5575. PubMed ID: 38114149
[TBL] [Abstract][Full Text] [Related]
7. Jiang-Zhi granules decrease sensitivity to low-dose CCl
Yang L; Zhou Y; Song H; Zheng P
BMC Complement Altern Med; 2019 Aug; 19(1):228. PubMed ID: 31438932
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
Tang W; Yao X; Xia F; Yang M; Chen Z; Zhou B; Liu Q
Oxid Med Cell Longev; 2018; 2018():7261619. PubMed ID: 30671174
[TBL] [Abstract][Full Text] [Related]
9. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
10. Effect of Different Exercise Intensities on Hepatocyte Apoptosis in HFD-Induced NAFLD in Rats: The Possible Role of Endoplasmic Reticulum Stress through the Regulation of the IRE1/JNK and eIF2
Ruan L; Li F; Li S; Zhang M; Wang F; Lv X; Liu Q
Oxid Med Cell Longev; 2021; 2021():6378568. PubMed ID: 33815655
[TBL] [Abstract][Full Text] [Related]
11. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
12. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway.
Chen Z; Liu Y; Yang L; Liu P; Zhang Y; Wang X
Immunol Lett; 2020 Jun; 222():40-48. PubMed ID: 32194141
[TBL] [Abstract][Full Text] [Related]
13. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
[No Abstract] [Full Text] [Related]
14. Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease.
Tang W; Zeng L; Yin J; Yao Y; Feng L; Yao X; Sun X; Zhou B
Evid Based Complement Alternat Med; 2015; 2015():810369. PubMed ID: 26146507
[TBL] [Abstract][Full Text] [Related]
15. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
16. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE
Nasiri-Ansari N; Nikolopoulou C; Papoutsi K; Kyrou I; Mantzoros CS; Kyriakopoulos G; Chatzigeorgiou A; Kalotychou V; Randeva MS; Chatha K; Kontzoglou K; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467546
[TBL] [Abstract][Full Text] [Related]
17. Effects of electroacupuncture of different intensities and durations on PERK/ATF4/CHOP signaling pathway in liver of non-alcoholic fatty liver disease rats.
Luo A; Yu M; Li G; Tang CL; Zhong XY; DU YY
Zhen Ci Yan Jiu; 2024 Apr; 49(4):358-366. PubMed ID: 38649203
[TBL] [Abstract][Full Text] [Related]
18. Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease.
Xie Q; Gao S; Lei M; Li Z
Aging (Albany NY); 2022 Feb; 14(3):1265-1279. PubMed ID: 35143415
[TBL] [Abstract][Full Text] [Related]
19. Pollen Typhae Total Flavone Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis in Human Aortic-Vascular Smooth Muscle Cells through Down-Regulating PERK-eIF2α-ATF4-CHOP Pathway.
Chen MT; Huang RL; Ou LJ; Chen YN; Men L; Chang X; Wang L; Yang YZ; Zhang Z
Chin J Integr Med; 2019 Aug; 25(8):604-612. PubMed ID: 30707413
[TBL] [Abstract][Full Text] [Related]
20. [Effect and mechanism of Bidens pilosa decoction on non-alcoholic fatty liver induced by high fat and high glucose in mice].
Gao XL; Duan LX; Qiu KK; Guo ML; Jiao YL; Wang DM
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(16):3915-3921. PubMed ID: 32893589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
